Thanks to the integrated technologies of micro-and nano-HPLC and Q-STAR LC/MS + MS/MS, CBM is able to offer extensive and thorough service to carry out drug development and analysis. Its primary objective is to offer comprehensive and analytical chemical investigations in support of clinical chemotherapeutic drug development studies or standard drug regimens.